S. Kudoh

发表

Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule.

M. Fukuoka, N. Masuda, N. Yamamoto, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors.

M. Fukuoka, N. Yamamoto, H. Swaisland, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

M. Fukuoka, K. Kubota, M. Takada, 1997, Cancer Chemotherapy and Pharmacology.

Randomized phase III study of docetaxel (D) versus vinorelbine (V) for elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of a West Japan Thoracic Oncology Group trial (WJTOG9904)

M. Fukuoka, M. Takada, T. Satoh, 2005 .